EIZO (6737) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
18 Mar, 2026Executive summary
Net sales for the first half of FY2025 reached JPY 37,874M, up 2.9% year-over-year, with growth in Healthcare, Amusement, and Other segments offsetting declines in B&P, Creative Work, and V&S, and sluggish demand in Europe.
Operating profit declined to JPY 659M, down 20.5% year-over-year, mainly due to higher SG&A expenses from wage increases, new Technology Hub costs, and sales expansion in India and the Middle East.
Net income attributable to owners rose to JPY 930M, up 31.2% year-over-year, aided by foreign exchange gains compared to losses in the prior year.
Ordinary profit increased 39.4% to JPY 1,492M, supported by FX gains.
Demand and profitability are expected to be stronger in the second half, consistent with historical seasonality.
Financial highlights
Net sales: JPY 37,874M (102.9% YoY); gross profit: JPY 12,346M (103.1% YoY); gross margin: 32.6% (up 0.1pt YoY).
Operating profit: JPY 659M (79.5% YoY); operating margin: 1.7% (down 0.5pt YoY).
Ordinary profit: JPY 1,492M (139.4% YoY); profit attributable to owners: JPY 930M (131.2% YoY).
SG&A expenses increased 4.9% YoY to JPY 11,686M, driven by personnel, new Technology Hub costs, and expanded sales activities.
Basic EPS was JPY 22.61, up from JPY 17.24 after a 2-for-1 share split.
Outlook and guidance
FY2025 full-year guidance maintained: net sales JPY 85B (+5.6% YoY), operating profit JPY 4.8B (+29.5% YoY), net income JPY 4.4B (+6.1% YoY), EPS JPY 106.90.
Sales and profits expected to be concentrated in the second half, especially in Healthcare (Japan) and V&S (overseas) segments.
Strict control over fixed costs to be enforced.
No revisions to previously announced forecasts.
Latest events from EIZO
- Profits fell on weak demand, but full-year growth and a share split are forecast.6737
Q1 202518 Mar 2026 - Profits and comprehensive income fell sharply, with a modest sales outlook and share split enacted.6737
Q2 202518 Mar 2026 - Profits dropped despite stable sales, with unchanged guidance and a recent share split.6737
Q3 202518 Mar 2026 - Flat sales and lower profit, but FY2026 outlook targets growth and higher dividends.6737
Q4 202518 Mar 2026 - Sales and profits fell on European weakness, but margin and new products support future outlook.6737
Q1 202618 Mar 2026 - Net sales rose, but profit outlook was cut due to higher costs and weak European demand.6737
Q3 202618 Mar 2026